EEM vs IBB
iShares MSCI Emerging Markets ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.72% for EEM.
- • EEM pays a higher dividend yield (1.83%).
Side-by-side metrics
| Metric | EEM | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.72% | 0.44% |
Dividend yield Trailing 12-month yield. | 1.83% | 0.16% |
AUM Assets under management — bigger funds are typically more liquid. | $28.25B | $11.50B |
YTD return | 12.11% | 30.22% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.07 | 0.60 |
P/E ratio | 14.62 | 25.48 |
Last price | $62.27 | $217.75 |
Inception | — | — |
Issuer | iShares | iShares |
EEM top holdings
| 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 15.84% |
| 005930.KQ | Samsung Electronics Co Ltd | 6.98% |
| 000660.KQ | SK hynix Inc | 5.19% |
| 0700.HK | Tencent Holdings Ltd | 2.65% |
| 9988.HK | Alibaba Group Holding Ltd Ordinary Shares | 1.84% |
| 2454.TW | MediaTek Inc | 1.53% |
| 00939 | China Construction Bank Corp Class H | 0.97% |
| 2317.TW | Hon Hai Precision Industry Co Ltd | 0.82% |
| HDFCBANK.NS | HDFC Bank Ltd | 0.74% |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
About EEM
EEM (iShares MSCI Emerging Markets ETF) is Liquid emerging-market equities. Managed by iShares, the fund carries $28.2B in assets under management, an expense ratio of 0.72%, a dividend yield of 1.83%. Its largest holding is Taiwan Semiconductor Manufacturing Co Ltd (2330.TW), which represents 15.8% of the portfolio. Real Estate is the fund's largest sector exposure at 1.0%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.